Production and characterization of recombinantly derived peptides and antibodies for accurate determinations of somatolactin, growth hormone and insulin-like growth factor-I in European sea bass (Dicentrarchus labrax).
A specific radioimmunoassay (RIA) for European sea bass (Dicentrarchus labrax) growth hormone (GH) was developed and validated. For this purpose, a stable source of GH was produced by means of recombinant DNA technology in a bacteria system. The identity of the purified protein (ion exchange chromatography) was demonstrated by Western blot and a specific GH antiserum was raised in rabbit. In Western blot and RIA system, this antiserum recognized specifically native and recombinant GH, and it did not cross-react with fish prolactin (PRL) and somatolactin (SL). In a similar way, a specific polyclonal antiserum against the now available recombinant European sea bass SL was raised and used in the RIA system to a sensitivity of 0.3 ng/ml (90% of binding of tracer). Further, European sea bass insulin-like growth factor-I (IGF-I) was cloned and sequenced, and its high degree of identity with IGF-I peptides of barramundi, tuna, and sparid fish allowed the use of a commercial IGF-I RIA based on barramundi IGF-I antiserum. These assay tools assisted for the first time accurate determinations of SL and GH-IGF-I axis activity in a fish species of the Moronidae family. Data values were compared to those found with gilthead sea bream (Sparus aurata), which is currently used as a Mediterranean fish model for growth endocrinology studies. As a characteristic feature, the average concentration year round of circulating GH in growing mature males of European sea bass was higher than in gilthead sea bream. By contrast, the average concentration of circulating SL was lower. Concerning to circulating concentration of IGF-I, the measured plasma values for a given growth rate were also lower in European sea bass. These findings are discussed on the basis of a different energy status that might allowed a reduced but more continuous growth in European sea bass.
de Celis
S Vega-Rubín
SV
Instituto de Acuicultura de Torre de la Sal (CSIC), 12595 Ribera de Cabanes, Castellón, Spain.
Gómez-Requeni
P
P
Pérez-Sánchez
J
J
D000595:Amino Acid Sequence; D000818:Animals; D000917:Antibody Formation; D001492:Bass / Q000097:blood / Q000254:growth & development / Q000378:metabolism*; D015153:Blotting, Western; D029941:Fish Proteins; D005399:Fishes / Q000378:metabolism; D006023:Glycoproteins / Q000097:blood / Q000378:metabolism*; D013006:Growth Hormone / Q000096:biosynthesis / Q000097:blood / Q000737:chemistry / Q000378:metabolism*; D007106:Immune Sera; D007334:Insulin-Like Growth Factor I / Q000235:genetics / Q000378:metabolism; D008297:Male; D010455:Peptides; D010907:Pituitary Hormones / Q000097:blood / Q000378:metabolism*; D011817:Rabbits; D011863:Radioimmunoassay / Q000592:standards*; D011994:Recombinant Proteins / Q000096:biosynthesis; D021541:Sea Bream / Q000097:blood / Q000254:growth & development / Q000378:metabolism; D012621:Seasons
D029941:Fish Proteins; D006023:Glycoproteins; D007106:Immune Sera; D010455:Peptides; D010907:Pituitary Hormones; D011994:Recombinant Proteins; C064448:somatolactin protein, fish; D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone